Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-12.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 100 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 101 Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > Endocrinol Metab > Volume 36(1); 2021 > Article
Brief Report
Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study
Wonjun Ji1*orcid, Rugyeom Lee2*orcid, Kyungmin Huh3, Minsun Kang2, In Cheol Hwang4, Munkhzul Radnaabaatar2, Dae Ho Lee5orcid, Jaehun Jung2,6orcid
Endocrinology and Metabolism 2021;36(1):196-200.
DOI: https://doi.org/10.3803/EnM.2020.856
Published online: February 24, 2021

1Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

2Artificial Intelligence and Big-Data Convergence Center, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

3Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

4Department of Family Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

5Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, Incheon, Korea

6Department of Preventive Medicine, Gachon University College of Medicine, Incheon, Korea

Corresponding authors: Jaehun Jung. Department of Preventive Medicine, Gachon University College of Medicine, 38 Dokjeom-ro 3beon-gil, Namdong-gu, Incheon 21565, Korea, Tel: +82-32-458-2611, Fax: +82-32-458-2608, E-mail: eastside1st@gmail.com
Dae Ho Lee. Department of Internal Medicine, Gachon University Gil Medical Center, Gachon University College of Medicine, 21 Namdong-daero 774beon-gil, Namdong-gu, Incheon 21565, Korea, Tel: +82-32-458-2733, Fax: +82-32-468-5836, E-mail: drhormone@naver.com
*These authors contributed equally to this work.
• Received: September 23, 2020   • Revised: December 14, 2020   • Accepted: January 19, 2021

Copyright © 2021 Korean Endocrine Society

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 6,252 Views
  • 233 Download
  • 8 Web of Science
  • 10 Crossref
  • 9 Scopus
prev next
Full Article

Download PDF Download PDF

  • Although obesity is a risk factor for infection, whether it has the same effect on coronavirus disease 2019 (COVID-19) need confirming. We conducted a retrospective propensity score matched case-control study to examine the association between obesity and COVID-19. This study included data from the Nationwide COVID-19 Registry and the Biennial Health Checkup database, until May 30, 2020. We identified 2,231 patients with confirmed COVID-19 and 10-fold-matched negative test controls. Overweight (body mass index [BMI] 23 to 24.9 kg/m2; adjusted odds ratio [aOR], 1.16; 95% confidence interval [CI], 1.1.03 to 1.30) and class 1 obesity (BMI 25 to 29.9 kg/m2; aOR, 1.27; 95% CI, 1.14 to 1.42) had significantly increased COVID-19 risk, while classes 2 and 3 obesity (BMI ≥30 kg/m2) showed similar but non-significant trend. Females and those <50 years had more robust association pattern. Overweight and obesity are possible risk factors of COVID-19.
  • Keywords: COVID-19; Obesity; Overweight; Infections
Coronavirus disease 2019 (COVID-19), caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in >28 million confirmed cases and 917,000 deaths as of mid-September 2020 [1]. Although previous epidemiological studies reported that obesity was associated with infectious diseases risk [2–4], whether it has the same effect on COVID-19 needs confirming.
We conducted a retrospective propensity score (PS) matched case-control study, to examine association between obesity and COVID-19 risk using data from the Nationwide Registry of COVID-19 cases and the Biennial Health Checkup database of South Korea.
Statement of ethics
This research was conducted in accordance with the ethics requirements of the World Medical Association Declaration of Helsinki and approved by Institutional Review Board of the Gachon University College of Medicine, Incheon, Republic of Korea (GFIRB2020-118), and written informed consent requirement was waived, since human subjects were not involved in the study.
Data sources
Data were obtained from the Korea Center for Disease Control and Prevention (KCDC) Nationwide COVID-19 Registry and the Biennial Health Checkup database of the National Health Insurance Service (NHIS) of South Korea, until May 30, 2020. The NHIS database was linked to the KCDC COVID-19 registry.
The data regarding comorbidities (identified using International Statistical Classification of Diseases and Related Health Problems, 10th Revision) were extracted from the NHIS reimbursement database and categorized in Supplemental Table S1. The comorbidities, identified from diagnostic codes, included at least twice according to the reimbursement records covering the past 3 years and dated before COVID-19 onset.
Study patients and definitions
Patients aged ≥20 years who underwent laboratory test for COVID-19 and NHIS health checkup in 2018 and later, were included. COVID-19 diagnosis was made using nasopharyngeal swab or sputum sample, and analyzed using reverse transcriptase polymerase chain reaction to detect SARS-CoV-2 according to the national guidelines [5]. All patients who tested positive were categorized as confirmed cases and the remaining as negative controls. Data on body mass index (BMI) were categorized as normal (BMI <23 kg/m2), overweight (BMI 23.0 to 24.9 kg/m2), class 1 obesity (BMI 25.0 to 29.9 kg/m2), and classes 2 and 3 obesity (BMI ≥30 kg/m2) according to the Korean Society for the Study of Obesity guidelines (Supplemental Table S2) [6]. As the primary outcome, association between infection of COVID-19 and BMI categories was analyzed, and association with fasting blood sugar (FBS) was also evaluated.
Statistical analysis
Baseline characteristics of COVID-19 patients and test negative controls were compared using chi-square test and Student’s t test, as appropriate. Charlson comorbidity index (CCI) was calculated using standard methods [7] and compared. Adjusted logistic regression models were constructed, based on the following covariates: age, sex, NHIS expanded medical aid coverage, and comorbidities. We constructed PS matched cohorts to mitigate the impact of confounders. PSs for COVID-19 risk were calculated using logistic regressions including the following covariates: age, sex, medical aid coverage, and CCI. Each patient with COVID-19 was matched with up to 10 test negative controls using the greedy neighbor nearest-matching algorithm (Fig. 1). The model was further adjusted in a logistic regression analysis, using age, sex, insurance medical aid coverage, and comorbidities, as covariates. The standardized mean difference in PS matching are presented in Supplemental Table S3. All statistical tests were two-tailed and the threshold for significance was set at P values <0.05. All analyses were performed using SAS software version 9.4 (SAS Institute Inc., Cary, NC, USA).
Baseline demographics between cases and test negative controls
A total of 76,332 individuals aged ≥20 years who underwent a laboratory test for COVID-19 and the NHIS health checkup in 2018 and later, were identified. From the 74,101 negative test controls, 10-fold PS matched controls were selected and analyzed (Fig. 1).
The proportion of females (1,360 of 2,231; 61.0%) and those with medical aid (142 of 2,231; 6.4%) were higher among positive cases than the negative controls. COVID-19 patient group were older than those in the control group. After PS matching, the matched cohort showed similar baseline characteristics except for the proportion with medical aid, diabetes, chronic liver disease, malignancy, and rheumatologic disease (Supplemental Table S4).
Association between BMI category and COVID-19
Overall, higher BMI showed positive association with COVID-19 (Fig. 2). Patients who were overweight (adjusted odds ratio [aOR], 1.16; 95% confidence interval [CI], 1.03 to 1.30; P= 0.015) and had class 1 obesity (aOR, 1.27; 95% CI, 1.14 to 1.42; P<0.001) had significantly increased risk of COVID-19 compared to those with normal BMI reading, while patients with classes 2 and 3 obesity showed similar but not significant trend (aOR, 1.18; 95% CI, 0.95 to 1.46; P=0.128). The effect of BMI on the risk of COVID-19 was more prominent among women than among men. By age group, the association patterns of overweight and class 1 obesity were robust for all age groups. Classes 2 and 3 obesity showed a significant association in <50 years age group (aOR, 1.57; 95% CI, 1.15 to 2.13; P=0.004).
Association between fasting blood glucose category and COVID-19
FBS ≥126 mg/dL was significantly associated with COVID-19 only in females (aOR, 1.33; 95% CI, 1.05 to 1.69; P=0.02), while the other groups and overall analysis did not show significant differences (Supplemental Table S5).
In this study, we found overweight and obesity as possible risk factors of COVID-19, especially in females and in <50 years age group. Our findings are consistent with previous reports, which revealed obesity as a significant risk factor for the occurrence, severity, and mortality of COVID-19 [8–12]. Increased expression levels of angiotensin-converting enzyme 2 by adipocytes, overactive renin-angiotensin system due to higher levels of angiotensin II, endothelial dysfunction, and higher risk of thromboembolism have been proposed as possible mechanisms linking obesity with COVID-19 risk [13–15].
The present study found that class 1 obesity (BMI 25.0 to 29.9 kg/m2) was also a significant risk factor for COVID-19. Moreover, higher BMI and FBS ≥126 mg/dL were more significantly associated with COVID-19 in females than in males. Some previous studies reported that there may be gender differences in susceptibility to COVID-19 [16,17], and the present study results also suggest this. Interestingly, classes 2 and 3 obesity were significantly associated with increased COVID-19 risk in <50 years age group, while a similar but not significant trend was shown in the older age groups. A small retrospective study reported obesity as a predictive factor affecting COVID-19 severity in young adults <40 years old [18]. This previous report is supported by findings of our study indicating that obesity may have a greater impact on COVID-19 in younger adults.
This study has a few limitations. First, there is the possibility of selection bias. We used data of patients who underwent health checkups in 2018 or later, and it is possible that these patients were more likely to have undergone health checkups, as they may have had more comorbidities. However, to mitigate this confounding factor, we used a robust design with the PS matched analysis. Moreover, we consider that the results reflected more accurately the current body weight, because we used the most recent heath checkup data. Second, we were unable to evaluate the mechanism of the relationship between obesity and COVID-19. However, this study findings confirmed the association between obesity and COVID-19 and we recommend that detailed mechanisms of the relationship be evaluated by further experimental research.
In conclusion, overweight and obesity are possible risk factors of COVID-19, especially in females and in those aged <50 years. Therefore, weight and obesity approaches are important considerations in COVID-19 pandemic prevention and control.
Supplemental Table S1.
ICD-10 Codes Used for the Identification of Comorbidities
enm-2020-856-suppl1.pdf
Supplemental Table S2.
Classification of Blood Pressure, Fasting Plasma Glucose, Body Mass Index, and Lipid Profile
enm-2020-856-suppl2.pdf
Supplemental Table S3.
Standardized Mean Differences of Propensity Score Matching and Multiple Logistic Regression Analysis
enm-2020-856-suppl3.pdf
Supplemental Table S4.
Baseline Characteristics of Patients Who Received Laboratory Test of COVID-19 after Propensity Score Matching
enm-2020-856-suppl4.pdf
Supplemental Table S5.
Adjusted ORs for Patients Who Were Confirmed with COVID-19 and Negative Test Controls (Hypertension and Fasting Blood Sugar)
enm-2020-856-suppl5.pdf
Acknowledgements
The authors would like to thank all the healthcare professionals dedicated to the treatment of patients with COVID-19 in Korea; and the Ministry of Health and Welfare and the National Health Insurance Service of Korea for their prompt sharing of invaluable national health insurance claims data.
This study was supported by grants from the Gachon University Gil Medical Center (grant numbers 2019-11) and a grant from the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare, Korea (grant numbers HI14C1135). The sponsors of the study were not involved in the study design, analysis, interpretation of data, and the writing of the report; nor the decision to submit the findings of the study for publication.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

AUTHOR CONTRIBUTIONS

Conception or design: W.J., K.H., I.C.H., D.H.L., J.J. Acquisition, analysis, or interpretation of data: W.J., R.L., K.H., I.C.H., D.H.L., J.J. Drafting the work or revising: W.J., D.H.L. Final approval of the manuscript: W.J., R.L., K.H., M.K., I.C.H., M.R., D.H.L., J.J.

Fig. 1
Flowchart of the patient selection process. COVID-19, coronavirus disease 2019; NHIS, National Health Insurance Service.
enm-2020-856f1.jpg
Fig. 2
Adjusted odds ratios (ORs) for patients who were confirmed with coronavirus disease 2019 and the negative test controls. CI, confidence interval; PS, propensity score.
enm-2020-856f2.jpg
  • 1. World Health Organization. Coronavirus disease (COVID-19) Weekly Epidemiological Update and Weekly Operational Update [Internet] Geneva: WHO; 2020 [cited 2021 Jan 30]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports .
  • 2. Dobner J, Kaser S. Body mass index and the risk of infection: from underweight to obesity. Clin Microbiol Infect 2018;24:24–8.ArticlePubMed
  • 3. Kaspersen KA, Pedersen OB, Petersen MS, Hjalgrim H, Rostgaard K, Moller BK, et al. Obesity and risk of infection: results from the Danish Blood Donor Study. Epidemiology 2015;26:580–9.ArticlePubMed
  • 4. Maccioni L, Weber S, Elgizouli M, Stoehlker AS, Geist I, Peter HH, et al. Obesity and risk of respiratory tract infections: results of an infection-diary based cohort study. BMC Public Health 2018;18:271.ArticlePubMedPMC
  • 5. Korea Center for Disease Control and Prevention. COVID-19 Response Guidelines (Edition 8.1) [Internet] Sejong: KCDC; 2020 [cited 2021 Jan 30]. Available from: http://ncov.mohw.go.kr/shBoardView.do?brdId=2&brdGubun=28&ncvContSeq=2447 .
  • 6. Seo MH, Lee WY, Kim SS, Kang JH, Kang JH, Kim KK, et al. 2018 Korean Society for the Study of Obesity guideline for the management of obesity in Korea. J Obes Metab Syndr 2019;28:40–5.ArticlePubMedPMC
  • 7. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83.ArticlePubMed
  • 8. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes Rev 2020;21:e13128.ArticlePubMedPMC
  • 9. Wang J, Zhu L, Liu L, Zhao XA, Zhang Z, Xue L, et al. Overweight and obesity are risk factors of severe illness in patients with COVID-19. Obesity (Silver Spring) 2020;28:2049–55.ArticlePubMedPMC
  • 10. Singh S, Bilal M, Pakhchanian H, Raiker R, Kochhar GS, Thompson CC. Impact of obesity on outcomes of patients with coronavirus disease 2019 in the United States: a multicenter electronic health records network study. Gastroenterology 2020;159:2221–5.ArticlePubMedPMC
  • 11. Hamer M, Gale CR, Kivimaki M, Batty GD. Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom. Proc Natl Acad Sci U S A 2020;117:21011–3.ArticlePubMedPMC
  • 12. Czernichow S, Beeker N, Rives-Lange C, Guerot E, Diehl JL, Katsahian S, et al. Obesity doubles mortality in patients hospitalized for severe acute respiratory syndrome coronavirus 2 in Paris hospitals, France: a cohort study on 5,795 patients. Obesity (Silver Spring) 2020;28:2282–9.ArticlePubMedPMC
  • 13. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc 2020;95:1445–53.ArticlePubMedPMC
  • 14. Pasquarelli-do-Nascimento G, Braz-de-Melo HA, Faria SS, Santos IO, Kobinger GP, Magalhaes KG. Hypercoagulopathy and adipose tissue exacerbated inflammation may explain higher mortality in COVID-19 patients with obesity. Front Endocrinol (Lausanne) 2020;11:530.PubMedPMC
  • 15. Cinti S, Graciotti L, Giordano A, Valerio A, Nisoli E. COVID-19 and fat embolism: a hypothesis to explain the severe clinical outcome in people with obesity. Int J Obes (Lond) 2020;44:1800–2.ArticlePubMedPMC
  • 16. Lubrano C, Masi D, Risi R, Balena A, Watanabe M, Mariani S, et al. Is growth hormone insufficiency the missing link between obesity, male gender, age, and COVID-19 severity? Obesity (Silver Spring) 2020;28:2038–9.ArticlePubMedPMC
  • 17. Rapp JL, Lieberman-Cribbin W, Tuminello S, Taioli E. Male sex, severe obesity, older age, and chronic kidney disease are associated with COVID-19 severity and mortality in New York City. Chest 2021;159:112–5.ArticlePubMed
  • 18. Deng M, Qi Y, Deng L, Wang H, Xu Y, Li Z, et al. Obesity as a potential predictor of disease severity in young COVID-19 patients: a retrospective study. Obesity (Silver Spring) 2020;28:1815–25.ArticlePubMedPMC

Figure & Data

References

    Citations

    Citations to this article as recorded by  
    • The association between excess weight and COVID‐19 outcomes: An umbrella review
      Jamie Matu, Alex Griffiths, Oliver M. Shannon, Andrew Jones, Rhiannon Day, Duncan Radley, Alison Feeley, Lisa Mabbs, Jamie Blackshaw, Naveed Sattar, Louisa Ells
      Obesity Reviews.2024;[Epub]     CrossRef
    • Risk for Newly Diagnosed Type 2 Diabetes Mellitus after COVID-19 among Korean Adults: A Nationwide Matched Cohort Study
      Jong Han Choi, Kyoung Min Kim, Keeho Song, Gi Hyeon Seo
      Endocrinology and Metabolism.2023; 38(2): 245.     CrossRef
    • Systematic review with meta‐analysis: COVID‐19 outcomes in patients receiving anti‐TNF treatments
      Georgios Kokkotis, Konstantina Kitsou, Ioannis Xynogalas, Vana Spoulou, Gkikas Magiorkinis, Ioannis Trontzas, Panagiotis Trontzas, Garyphallia Poulakou, Konstantinos Syrigos, Giorgos Bamias
      Alimentary Pharmacology & Therapeutics.2022; 55(2): 154.     CrossRef
    • Association between COVID-19 morbidity, mortality, and gross domestic product, overweight/ obesity, non-communicable diseases, vaccination rate: A cross-sectional study
      Kuat Oshakbayev, Zulfiya Zhankalova, Meruyert Gazaliyeva, Khalit Mustafin, Gulnara Bedelbayeva, Bibazhar Dukenbayeva, Nurzhan Otarbayev, Attila Tordai
      Journal of Infection and Public Health.2022; 15(2): 255.     CrossRef
    • Association between being underweight and excess body weight before SARS coronavirus type 2 infection and clinical outcomes of coronavirus disease 2019: Multicenter study
      João Araújo Barros-Neto, Carolina Santos Mello, Sandra Mary Lima Vasconcelos, Gabriel Soares Bádue, Raphaela Costa Ferreira, Maria Izabel Siqueira de Andrade, Carlos Queiroz do Nascimento, Mateus de Lima Macena, José Adailton da Silva, Heleni Aires Clemen
      Nutrition.2022; 101: 111677.     CrossRef
    • Impact of COVID-19 Lockdown on Non-Alcoholic Fatty Liver Disease and Insulin Resistance in Adults: A before and after Pandemic Lockdown Longitudinal Study
      Ángel Arturo López-González, Bárbara Altisench Jané, Luis Masmiquel Comas, Sebastiana Arroyo Bote, Hilda María González San Miguel, José Ignacio Ramírez Manent
      Nutrients.2022; 14(14): 2795.     CrossRef
    • Trends of overweight and obesity prevalence in school-aged children among Henan Province from 2000 to 2019
      Yuhao Zhang, Hao Lou, Ye Huang, Ruijuan Wang, Xiao Wen, Cuiping Wu, Changfu Hao, Ran Li, Genli Gao, Xiaomin Lou, Xian Wang
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • The effects of 105 biological, socioeconomic, behavioral, and environmental factors on the risk of SARS-CoV-2 infection and a severe course of COVID-19: a prospective, explorative cohort study
      Jaroslav Flegr, Pavel Flegr, Lenka Příplatová
      Biology Methods and Protocols.2022;[Epub]     CrossRef
    • Current status of health promotion in Korea
      Soo Young Kim
      Journal of the Korean Medical Association.2022; 65(12): 776.     CrossRef
    • Obesity and Coronavirus Disease 2019
      Min-Ji Kim, Jae-Han Jeon
      Journal of Metabolic and Bariatric Surgery.2021; 10(1): 1.     CrossRef

    Figure
    • 0
    • 1
    Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study
    Image Image
    Fig. 1 Flowchart of the patient selection process. COVID-19, coronavirus disease 2019; NHIS, National Health Insurance Service.
    Fig. 2 Adjusted odds ratios (ORs) for patients who were confirmed with coronavirus disease 2019 and the negative test controls. CI, confidence interval; PS, propensity score.

    Fig. 1

    Fig. 2

    Overweight and Obesity are Risk Factors for Coronavirus Disease 2019: A Propensity Score-Matched Case-Control Study
    Endocrinol Metab : Endocrinology and Metabolism
    © Korean Endocrine Society.
    TOP